Investment Analysis 12 February 2026 - 7 May 2026

London Stock Exchange Group shares fell 1.6% to 8,320 pence by 1415 GMT Thursday, underperforming despite a buyback of 352,244 shares for cancellation. The FTSE 100 dropped 1.1% amid broader market declines linked to Middle East tensions and rate hike fears. LSEG paid an average 8,516.81 pence per share in its latest buyback. The company forecasts 2026 organic income growth of 6.5% to 7.5%.

AppLovin shares closed up 1.4% at $438.89 Tuesday, then slipped 0.8% after hours. The stock swung between $406.10 and $444.16 during the session. Analyst targets diverged ahead of the company’s Wednesday appearance at the Morgan Stanley Technology, Media & Telecom Conference. An SEC investigation into AppLovin remains active.

Hims & Hers Health shares fell 0.5% to $15.46 in late trading Tuesday after BTIG downgraded the stock to “neutral,” citing regulatory risks and slowing growth. The company faces scrutiny over compounded weight-loss drugs and a potential Department of Justice probe. First-quarter revenue guidance missed analyst expectations, triggering a 7% after-hours drop Monday.

Klarna shares fell 26.9% to $13.85, their steepest drop since the company’s September 2025 NYSE debut. The firm posted a $26 million Q4 net loss, missing analyst expectations, as costs and credit provisions climbed. Revenue rose 38% to $1.082 billion, but funding and processing expenses surged. Klarna will release full annual results on February 26.

ICON shares jumped 16% in after-hours trading Friday, recovering some losses after a 40% plunge tied to an internal accounting probe and delayed earnings. The company withdrew 2025 guidance and postponed results to late April as it reviews revenue recognition for 2023–2025. Analysts at Leerink and BofA downgraded the stock and slashed price targets. ICON expects to report material weaknesses in internal controls.